Clinical trial data available for UX001, aceneuramic acid extended-release. | J Neurol Sci;411: 116724, 2020 04 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Clinical trial data available for UX001, aceneuramic acid extended-release.

Bedrosian, Camille L.

Affiliation

Bedrosian CL; Ultragenyx Pharmaceutical Inc., Novato, CA, United States. Electronic address: publications@ultragenyx.com.

J Neurol Sci ; 411: 116724, 2020 04 15.

Article in En | MEDLINE | ID: mdl-32058180

Subject(s)

Distal Myopathies; N-Acetylneuraminic Acid; Carbohydrate Epimerases; Humans

Key words

Aceneuramic acid extended-release; Glucosamine (UDP-N-acetyl)-2-epimerase myopathy; Inclusion body myopathy; Negative results

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: N-Acetylneuraminic Acid / Distal Myopathies Limits: Humans Language: En Journal: J Neurol Sci Year: 2020 Document type: Article Country of publication: Netherlands

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: N-Acetylneuraminic Acid / Distal Myopathies Limits: Humans Language: En Journal: J Neurol Sci Year: 2020 Document type: Article Country of publication: Netherlands